Education
About Us
Working with TipRanks
Follow Us
Robert Iannone Insider Profile
4 Followers
Robert Iannone, CMO at Immunomedics, holds ― shares in Immunomedics (Ticker: IMMU), holds 80.26K shares in Jazz Pharmaceuticals (Ticker: JAZZ), holds ― shares in Jounce Therapeutics (Ticker: JNCE). Most recently, Robert Iannone ― shares of Immunomedics on ― for an estimated value of ―.
Robert Iannone Immunomedics (IMMU)CMO
Immunomedics (IMMU)
CMO
Not Ranked
Robert Iannone has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
EVP, Global Head of R&D & CMO
Roles that Robert Iannone holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Robert Iannone
Robert Iannone's Trading History
Immunomedics
―
―
―
―
Jazz Pharmaceuticals
Jan 21, 2026
EVP, Global Head of R&D & CMO
Uninformative Buy
―
$13.61M
Jounce Therapeutics
―
―
―
―
iTeos Therapeutics
―
―
―
―
List of latest transactions for each holding click on a transaction to see Robert Iannone's performance on stock
You May Also Like
Robert Iannone insider profile FAQ
What is the percentage of profitable transactions made by Robert Iannone?
The percentage of profitable transactions made by Robert Iannone is ―.
What is the average return per transaction made by Robert Iannone?
The average return per transaction made by Robert Iannone is ―.
What stocks does Robert Iannone hold?
Robert Iannone holds: IMMU, JAZZ, JNCE, ITOS stocks.
What was Robert Iannone’s latest transaction?
Robert Iannone latest transaction was an Uninformative Buy of ―.
What was Robert Iannone's most profitable transaction?
Robert Iannone’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Robert Iannone's role in Immunomedics?
Robert Iannone's role in Immunomedics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.